Efficient development of stable and highly functionalised peptides targeting the CK2α/CK2β protein-protein interaction

Two‐Component Stapling of Biologically Active and Conformationally Constrained Peptides: Past, Present, and Future

Novel non-ATP competitive small molecules targeting the CK2 α/β interface

Stapled peptides as a new technology to investigate protein–protein interactions in human platelets

Second-generation CK2α inhibitors targeting the αD pocket.

A fragment-based approach leading to the discovery of a novel binding site and the selective CK2 inhibitor CAM4066

Binding Mode and Induced Fit Predictions for Prospective Computational Drug Design

Database Extraction of Metabolite Information of Drug Candidates: Analysis of 27 AstraZeneca Compounds with Human Absorption, Distribution, Metabolism, and Excretion Data

Salicylketoximes That Target Glucose Transporter 1 Restrict Energy Supply to Lung Cancer Cells.

Oxime-based inhibitors of glucose transporter 1 displaying antiproliferative effects in cancer cells